SlideShare a Scribd company logo
Donna Turner BSc, RRT, CRE
2018 PAS Conference
Regina, Sask.
May 13,2018
Happy Mother’s Day!!
Disclosures
 Astra Zeneca
 Glaxo SmithKline
 Boehringer Ingelheim
 Novartis
 U of S College of Nursing
 U of S College of Medicine
 Palliative Care Association-Prince Albert Division
 SIAST LPN program
 Lung Association of Saskatchewan
 Saskatchewan College of Respiratory Therapists
Outline
 Understand factors involved in therapeutic
effectiveness of inhaled medications.
 Factors involved in determining the right
device for each patient.
 How to educate patients on the proper use
of devices.
All inhalers are NOT created equal
 When inhalers are used correctly, there is little
difference in clinical efficacy between different inhaler
types
 Patients are not created equal and this is the only limit
of these devices, one inhaler does not fit all.
New inhaler devices - the good, the bad and the ugly.
Lavorini F, et al. Respiration 2014;88:3–15
Factors affecting therapeutic
effectiveness of inhaled meds
 Particle size of delivered med
 Resistance within dry powder devices
 Inspiratory flow by patient
 Coordination of activation of device and inhalation
 Correct inhaler use
Particle size and its importance
http://www.slideshare.net/ashrafeladawy/asthma-inhaler-techniques
Inspiratory resistance in DPIs
 Low resistance devices
 Breezhaler
 Medium resistance devices
 Ellipta/Genuair/Diskus
 High resistance devices
 Turbuhaler/Handihaler
Dry powder inhalers and the right things to remember: a concept review
Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13
Inspiratory flows
20
Inhalation device requirements for patients' inhalation maneuvers
PeterHaidl ,et al
Coordination of inhalation and activation
 MDI vs SMI vs DPI
 DPI are breath actuated, so timing of inhalation is not
an issue and some are pre loaded for easier use.
 MDI and SMI require coordination of timing of
inhalation with activation of delivery of med
 Some inhalers have numerous steps involved in the
delivery of inhaled med and this can lead to missteps in
the procedure
What is the right device?
Base this on:
 Ability of pt to coordinate device optimally
 Ability to reach peak inspiratory flow for device
 Physical Limitations
Arthritis
Tremor
Poor Eyesight
 Consider possible poor medication delivery during acute
“attacks”
 Advancing disease
 Allowing pts to handle different devices and have a choice
 Does the pt feel the med is working?
Checking device use and education
Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease.
Batterink J, et al. Can J Hosp Pharm. 2012.
Education is the key to success
Common errors with devices
How to educate?
A few points to
consider…
Metered Dose Inhaler ®
• Ventolin
• Atrovent
• Airomir
• Flovent/Alvesco/Qvar
• Advair/Zenhale
Discus ®
• Ventolin
• Flovent
• Advair
• Serevent
Turbuhaler ®
• Bricanyl
• Oxeze
• Pulmicort
• Symbicort
Handihaler ®
• Spiriva
Twisthaler ®
• Asmanex
Breezhaler ®
•Seebri
•Onbrez
•Ultibro
Ellipta®
•Incruse
•Anoro
•Breo
•Arnuity
Genuair ®
•Tudorza
•Duaklir
Respimat ®
•Combivent
•Spiriva
•Striverdi
•Inspiolto
We can’t do it alone….
Teamwork
divides the
task and
multiplies
the
success….
Medication and Delivery Devices
www.sk.lung.ca/resptrec-resources
CREs
https://mcarthurmedical.com
http://respiralogics.com
References
1.Evaluation of the use of inhaled medications by hospital inpatients with chronic
obstructive pulmonary disease.J, et al. Can J Hosp Pharm. 2012.
2.Rx Files –COPD New Drugs, New Devices and Considerations for Best Practice Sept/15
3. The Science of Respiratory Medication Delivery Information taken from a
2014Webinar presentation by Dr. Janice Leung, MD
4.New inhaler devices - the good, the bad and the ugly.Lavorini F, et al. Respiration
2014;88:3–15
5.Inhaler Technique and Training in People With Chronic Obstructive Pulmonary
Disease and Asthma:Choosing the Correct Inhaler
Toby G.D. Capstick, MRPharmS; Ian J. Clifton, MD Medscape CME Released: 01/27/2012
6.Dry powder inhalers and the right things to remember: a concept review
Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13
7.Not all asthma inhalers are the same: factors to consider when prescribing an
inhaler Henry Chrystyna , David Pricea. Primary Care Respiratory Journal (2009)
8. http://www.specialconnections.ku.edu/?q=instruction/direct_instruction
9.Lung Association of Saskachewan-Inhaler videos and inhaler instruction sheets
10. Inhalation device requirements for patients' inhalation maneuvers PeterHaidl,et al
Thank-you!

More Related Content

What's hot

Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bassel Ericsoussi, MD
 
Respiratory devices 4 december 2018(21 nov)
Respiratory  devices 4 december 2018(21 nov)Respiratory  devices 4 december 2018(21 nov)
Respiratory devices 4 december 2018(21 nov)
Dr Ahmed Sayeed
 
Inhaled medication in bronchial asthma
Inhaled medication in bronchial asthmaInhaled medication in bronchial asthma
Inhaled medication in bronchial asthma
Raj Kumar
 
Common mistakes with inhalers
Common mistakes with inhalers Common mistakes with inhalers
Common mistakes with inhalers
Shira Persona
 
Inhaler devices
Inhaler devicesInhaler devices
Studies of biologic agents in severe asthma
Studies of biologic agents in severe asthmaStudies of biologic agents in severe asthma
Studies of biologic agents in severe asthma
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Asthma
Asthma  Asthma
Asthma
Richin Koshy
 
Inhaler therapy
Inhaler therapyInhaler therapy
Bronchial Thermoplasty
Bronchial ThermoplastyBronchial Thermoplasty
Bronchial Thermoplasty
cschoolmaster
 
Asthma - Recent advances in treatment
Asthma - Recent advances in treatmentAsthma - Recent advances in treatment
Asthma - Recent advances in treatmentDivya Krishnan
 
Bronchial thermoplasty
Bronchial thermoplastyBronchial thermoplasty
Bronchial thermoplasty
Narthanan mathiselvan
 
Immunotherapy in asthma
Immunotherapy in asthmaImmunotherapy in asthma
Immunotherapy in asthma
Khairul Jessy
 
Asthma a clinical review and its management
Asthma  a clinical review and its managementAsthma  a clinical review and its management
Asthma a clinical review and its management
Nani Karnam Vinayakam
 
Asthma Presentation
Asthma PresentationAsthma Presentation
Asthma Presentationkerri035
 
Pharmacotherapy in bronchial asthma and recent advances
Pharmacotherapy in bronchial asthma and recent advancesPharmacotherapy in bronchial asthma and recent advances
Pharmacotherapy in bronchial asthma and recent advances
Dr Resu Neha Reddy
 
GINA 2019 presentation
GINA 2019 presentationGINA 2019 presentation
GINA 2019 presentation
Dewan Shafiq
 
Bedaquiline
BedaquilineBedaquiline
Bedaquiline
PratikDhabalia
 
Spirometry Interpretation
Spirometry Interpretation Spirometry Interpretation
Spirometry Interpretation
Ashraf ElAdawy
 
Recent advances in the pharmacotherapy of asthma
Recent advances in the pharmacotherapy of asthmaRecent advances in the pharmacotherapy of asthma
Recent advances in the pharmacotherapy of asthma
Dr. Mohit Kulmi
 

What's hot (20)

Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
 
Respiratory devices 4 december 2018(21 nov)
Respiratory  devices 4 december 2018(21 nov)Respiratory  devices 4 december 2018(21 nov)
Respiratory devices 4 december 2018(21 nov)
 
Inhaled medication in bronchial asthma
Inhaled medication in bronchial asthmaInhaled medication in bronchial asthma
Inhaled medication in bronchial asthma
 
Common mistakes with inhalers
Common mistakes with inhalers Common mistakes with inhalers
Common mistakes with inhalers
 
Inhaler devices
Inhaler devicesInhaler devices
Inhaler devices
 
Studies of biologic agents in severe asthma
Studies of biologic agents in severe asthmaStudies of biologic agents in severe asthma
Studies of biologic agents in severe asthma
 
Inhaler Devices
Inhaler DevicesInhaler Devices
Inhaler Devices
 
Asthma
Asthma  Asthma
Asthma
 
Inhaler therapy
Inhaler therapyInhaler therapy
Inhaler therapy
 
Bronchial Thermoplasty
Bronchial ThermoplastyBronchial Thermoplasty
Bronchial Thermoplasty
 
Asthma - Recent advances in treatment
Asthma - Recent advances in treatmentAsthma - Recent advances in treatment
Asthma - Recent advances in treatment
 
Bronchial thermoplasty
Bronchial thermoplastyBronchial thermoplasty
Bronchial thermoplasty
 
Immunotherapy in asthma
Immunotherapy in asthmaImmunotherapy in asthma
Immunotherapy in asthma
 
Asthma a clinical review and its management
Asthma  a clinical review and its managementAsthma  a clinical review and its management
Asthma a clinical review and its management
 
Asthma Presentation
Asthma PresentationAsthma Presentation
Asthma Presentation
 
Pharmacotherapy in bronchial asthma and recent advances
Pharmacotherapy in bronchial asthma and recent advancesPharmacotherapy in bronchial asthma and recent advances
Pharmacotherapy in bronchial asthma and recent advances
 
GINA 2019 presentation
GINA 2019 presentationGINA 2019 presentation
GINA 2019 presentation
 
Bedaquiline
BedaquilineBedaquiline
Bedaquiline
 
Spirometry Interpretation
Spirometry Interpretation Spirometry Interpretation
Spirometry Interpretation
 
Recent advances in the pharmacotherapy of asthma
Recent advances in the pharmacotherapy of asthmaRecent advances in the pharmacotherapy of asthma
Recent advances in the pharmacotherapy of asthma
 

Similar to Inhaled Medications Used in Respiratory Disease

Inhaler Standards MASTER 6TH12
Inhaler Standards MASTER 6TH12Inhaler Standards MASTER 6TH12
Inhaler Standards MASTER 6TH12Jules Gaughan
 
Home nebulisation
Home nebulisationHome nebulisation
Home nebulisation
Jindal Chest Clinic
 
2
22
Inhalational devices.ppt
Inhalational devices.pptInhalational devices.ppt
Inhalational devices.ppt
Jindal Chest Clinic
 
Aderenta la tratamentul inhalator in bolile respiratorii
Aderenta la tratamentul inhalator in bolile respiratoriiAderenta la tratamentul inhalator in bolile respiratorii
Aderenta la tratamentul inhalator in bolile respiratorii
Traian Mihaescu
 
Nebulisation therapy in COVID 19 era.pptx
Nebulisation therapy in COVID 19 era.pptxNebulisation therapy in COVID 19 era.pptx
Nebulisation therapy in COVID 19 era.pptx
Jindal Chest Clinic
 
G047045049
G047045049G047045049
G047045049
iosrphr_editor
 
A Guide to Aerosol Delivery Devices for Respiratory Therapists
A Guide to Aerosol Delivery Devices for Respiratory TherapistsA Guide to Aerosol Delivery Devices for Respiratory Therapists
A Guide to Aerosol Delivery Devices for Respiratory Therapists
Utai Sukviwatsirikul
 
aerosol_handout
aerosol_handoutaerosol_handout
aerosol_handoutMike Hess
 
Use of inhalational devices in asthma Care
Use of inhalational devices in asthma CareUse of inhalational devices in asthma Care
Use of inhalational devices in asthma Care
Peter Odion Ubuane
 
CPAP- home nebulization.pptx
CPAP- home nebulization.pptxCPAP- home nebulization.pptx
UKIG Press Release final jan 17
UKIG Press Release  final jan 17UKIG Press Release  final jan 17
UKIG Press Release final jan 17Jules Gaughan
 
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose InhalerKnowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
SSR Institute of International Journal of Life Sciences
 
Incorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patientsIncorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patients
Anjum Hashmi MPH
 
Asthma In General Practice
Asthma In General PracticeAsthma In General Practice
Asthma In General Practice
Sherri Cost
 
Inhaler devices
Inhaler devicesInhaler devices
Inhaler devices
Harindu Udapitiya
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in Review
Marie Benz MD FAAD
 
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
DR. SUJOY MUKHERJEE
 
Ijpbs 52730df99c968
Ijpbs 52730df99c968Ijpbs 52730df99c968
Ijpbs 52730df99c968
Sams Pharmacy
 
Clinic practice of nebulized therapy in China(a national questionnaire survey)
Clinic practice of nebulized therapy in China(a national questionnaire survey)Clinic practice of nebulized therapy in China(a national questionnaire survey)
Clinic practice of nebulized therapy in China(a national questionnaire survey)Robin Jiang
 

Similar to Inhaled Medications Used in Respiratory Disease (20)

Inhaler Standards MASTER 6TH12
Inhaler Standards MASTER 6TH12Inhaler Standards MASTER 6TH12
Inhaler Standards MASTER 6TH12
 
Home nebulisation
Home nebulisationHome nebulisation
Home nebulisation
 
2
22
2
 
Inhalational devices.ppt
Inhalational devices.pptInhalational devices.ppt
Inhalational devices.ppt
 
Aderenta la tratamentul inhalator in bolile respiratorii
Aderenta la tratamentul inhalator in bolile respiratoriiAderenta la tratamentul inhalator in bolile respiratorii
Aderenta la tratamentul inhalator in bolile respiratorii
 
Nebulisation therapy in COVID 19 era.pptx
Nebulisation therapy in COVID 19 era.pptxNebulisation therapy in COVID 19 era.pptx
Nebulisation therapy in COVID 19 era.pptx
 
G047045049
G047045049G047045049
G047045049
 
A Guide to Aerosol Delivery Devices for Respiratory Therapists
A Guide to Aerosol Delivery Devices for Respiratory TherapistsA Guide to Aerosol Delivery Devices for Respiratory Therapists
A Guide to Aerosol Delivery Devices for Respiratory Therapists
 
aerosol_handout
aerosol_handoutaerosol_handout
aerosol_handout
 
Use of inhalational devices in asthma Care
Use of inhalational devices in asthma CareUse of inhalational devices in asthma Care
Use of inhalational devices in asthma Care
 
CPAP- home nebulization.pptx
CPAP- home nebulization.pptxCPAP- home nebulization.pptx
CPAP- home nebulization.pptx
 
UKIG Press Release final jan 17
UKIG Press Release  final jan 17UKIG Press Release  final jan 17
UKIG Press Release final jan 17
 
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose InhalerKnowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
Knowledge and Practice of Asthmatic’s Patients Regard using Meter Dose Inhaler
 
Incorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patientsIncorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patients
 
Asthma In General Practice
Asthma In General PracticeAsthma In General Practice
Asthma In General Practice
 
Inhaler devices
Inhaler devicesInhaler devices
Inhaler devices
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in Review
 
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
Evaluation of Empirical Usage of Respiratory Medications in Treatment of Pati...
 
Ijpbs 52730df99c968
Ijpbs 52730df99c968Ijpbs 52730df99c968
Ijpbs 52730df99c968
 
Clinic practice of nebulized therapy in China(a national questionnaire survey)
Clinic practice of nebulized therapy in China(a national questionnaire survey)Clinic practice of nebulized therapy in China(a national questionnaire survey)
Clinic practice of nebulized therapy in China(a national questionnaire survey)
 

More from PASaskatchewan

Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
PASaskatchewan
 
2019 PAS AGM Presentation
2019 PAS AGM Presentation2019 PAS AGM Presentation
2019 PAS AGM Presentation
PASaskatchewan
 
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
PASaskatchewan
 
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
PASaskatchewan
 
Pas marni panas 20180512
Pas marni panas 20180512Pas marni panas 20180512
Pas marni panas 20180512
PASaskatchewan
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
PASaskatchewan
 
Cannabis for pediatric epilepsy pas presentation for distribution
Cannabis for pediatric epilepsy pas presentation for distributionCannabis for pediatric epilepsy pas presentation for distribution
Cannabis for pediatric epilepsy pas presentation for distribution
PASaskatchewan
 
Poking Around the World of Immunizations
Poking Around the World of ImmunizationsPoking Around the World of Immunizations
Poking Around the World of Immunizations
PASaskatchewan
 
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPreventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
PASaskatchewan
 
Pharmacist Management of Hypertension
Pharmacist Management of HypertensionPharmacist Management of Hypertension
Pharmacist Management of Hypertension
PASaskatchewan
 
Saskatchewan Transfer Discharge Medication Reconciliation Form Overview
Saskatchewan Transfer Discharge Medication Reconciliation Form OverviewSaskatchewan Transfer Discharge Medication Reconciliation Form Overview
Saskatchewan Transfer Discharge Medication Reconciliation Form Overview
PASaskatchewan
 
SPEP Student Transition of Care Project
SPEP Student Transition of Care ProjectSPEP Student Transition of Care Project
SPEP Student Transition of Care Project
PASaskatchewan
 
Sask Travel Health Framework Overview
Sask Travel Health Framework OverviewSask Travel Health Framework Overview
Sask Travel Health Framework Overview
PASaskatchewan
 
Medicine Plants - Medicinal Ceremony
Medicine Plants - Medicinal CeremonyMedicine Plants - Medicinal Ceremony
Medicine Plants - Medicinal Ceremony
PASaskatchewan
 
Introduction to NAPRA Model Standards for Pharmacy Compounding
Introduction to NAPRA Model Standards for Pharmacy CompoundingIntroduction to NAPRA Model Standards for Pharmacy Compounding
Introduction to NAPRA Model Standards for Pharmacy Compounding
PASaskatchewan
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
PASaskatchewan
 
Medical Assistance in Dying
Medical Assistance in Dying Medical Assistance in Dying
Medical Assistance in Dying
PASaskatchewan
 
FASD Pharmacy presentation #1
FASD Pharmacy presentation #1FASD Pharmacy presentation #1
FASD Pharmacy presentation #1
PASaskatchewan
 
The Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
The Role of the Pharmacist in Fetal Alcohol Spectrum DisorderThe Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
The Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
PASaskatchewan
 
Points Business Proposal 2017
Points Business Proposal 2017Points Business Proposal 2017
Points Business Proposal 2017
PASaskatchewan
 

More from PASaskatchewan (20)

Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
Cancer 101: Managing Common Drug Interactions and External Supportive Care Me...
 
2019 PAS AGM Presentation
2019 PAS AGM Presentation2019 PAS AGM Presentation
2019 PAS AGM Presentation
 
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
Health and Well-Being: Historical,Present and Future Challenges for Indigenou...
 
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
Care Beyond Medication -Robyn Despins (PAS 2019 Conference)
 
Pas marni panas 20180512
Pas marni panas 20180512Pas marni panas 20180512
Pas marni panas 20180512
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
 
Cannabis for pediatric epilepsy pas presentation for distribution
Cannabis for pediatric epilepsy pas presentation for distributionCannabis for pediatric epilepsy pas presentation for distribution
Cannabis for pediatric epilepsy pas presentation for distribution
 
Poking Around the World of Immunizations
Poking Around the World of ImmunizationsPoking Around the World of Immunizations
Poking Around the World of Immunizations
 
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPreventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
 
Pharmacist Management of Hypertension
Pharmacist Management of HypertensionPharmacist Management of Hypertension
Pharmacist Management of Hypertension
 
Saskatchewan Transfer Discharge Medication Reconciliation Form Overview
Saskatchewan Transfer Discharge Medication Reconciliation Form OverviewSaskatchewan Transfer Discharge Medication Reconciliation Form Overview
Saskatchewan Transfer Discharge Medication Reconciliation Form Overview
 
SPEP Student Transition of Care Project
SPEP Student Transition of Care ProjectSPEP Student Transition of Care Project
SPEP Student Transition of Care Project
 
Sask Travel Health Framework Overview
Sask Travel Health Framework OverviewSask Travel Health Framework Overview
Sask Travel Health Framework Overview
 
Medicine Plants - Medicinal Ceremony
Medicine Plants - Medicinal CeremonyMedicine Plants - Medicinal Ceremony
Medicine Plants - Medicinal Ceremony
 
Introduction to NAPRA Model Standards for Pharmacy Compounding
Introduction to NAPRA Model Standards for Pharmacy CompoundingIntroduction to NAPRA Model Standards for Pharmacy Compounding
Introduction to NAPRA Model Standards for Pharmacy Compounding
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
 
Medical Assistance in Dying
Medical Assistance in Dying Medical Assistance in Dying
Medical Assistance in Dying
 
FASD Pharmacy presentation #1
FASD Pharmacy presentation #1FASD Pharmacy presentation #1
FASD Pharmacy presentation #1
 
The Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
The Role of the Pharmacist in Fetal Alcohol Spectrum DisorderThe Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
The Role of the Pharmacist in Fetal Alcohol Spectrum Disorder
 
Points Business Proposal 2017
Points Business Proposal 2017Points Business Proposal 2017
Points Business Proposal 2017
 

Recently uploaded

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
Esam43
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 

Recently uploaded (20)

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 

Inhaled Medications Used in Respiratory Disease

  • 1. Donna Turner BSc, RRT, CRE 2018 PAS Conference Regina, Sask. May 13,2018
  • 3. Disclosures  Astra Zeneca  Glaxo SmithKline  Boehringer Ingelheim  Novartis  U of S College of Nursing  U of S College of Medicine  Palliative Care Association-Prince Albert Division  SIAST LPN program  Lung Association of Saskatchewan  Saskatchewan College of Respiratory Therapists
  • 4. Outline  Understand factors involved in therapeutic effectiveness of inhaled medications.  Factors involved in determining the right device for each patient.  How to educate patients on the proper use of devices.
  • 5. All inhalers are NOT created equal  When inhalers are used correctly, there is little difference in clinical efficacy between different inhaler types  Patients are not created equal and this is the only limit of these devices, one inhaler does not fit all. New inhaler devices - the good, the bad and the ugly. Lavorini F, et al. Respiration 2014;88:3–15
  • 6. Factors affecting therapeutic effectiveness of inhaled meds  Particle size of delivered med  Resistance within dry powder devices  Inspiratory flow by patient  Coordination of activation of device and inhalation  Correct inhaler use
  • 7. Particle size and its importance http://www.slideshare.net/ashrafeladawy/asthma-inhaler-techniques
  • 8. Inspiratory resistance in DPIs  Low resistance devices  Breezhaler  Medium resistance devices  Ellipta/Genuair/Diskus  High resistance devices  Turbuhaler/Handihaler Dry powder inhalers and the right things to remember: a concept review Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13
  • 9. Inspiratory flows 20 Inhalation device requirements for patients' inhalation maneuvers PeterHaidl ,et al
  • 10. Coordination of inhalation and activation  MDI vs SMI vs DPI  DPI are breath actuated, so timing of inhalation is not an issue and some are pre loaded for easier use.  MDI and SMI require coordination of timing of inhalation with activation of delivery of med  Some inhalers have numerous steps involved in the delivery of inhaled med and this can lead to missteps in the procedure
  • 11. What is the right device? Base this on:  Ability of pt to coordinate device optimally  Ability to reach peak inspiratory flow for device  Physical Limitations Arthritis Tremor Poor Eyesight  Consider possible poor medication delivery during acute “attacks”  Advancing disease  Allowing pts to handle different devices and have a choice  Does the pt feel the med is working?
  • 12. Checking device use and education Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Batterink J, et al. Can J Hosp Pharm. 2012.
  • 13. Education is the key to success Common errors with devices
  • 15. A few points to consider…
  • 16. Metered Dose Inhaler ® • Ventolin • Atrovent • Airomir • Flovent/Alvesco/Qvar • Advair/Zenhale
  • 17. Discus ® • Ventolin • Flovent • Advair • Serevent
  • 18. Turbuhaler ® • Bricanyl • Oxeze • Pulmicort • Symbicort
  • 25. We can’t do it alone…. Teamwork divides the task and multiplies the success….
  • 26. Medication and Delivery Devices www.sk.lung.ca/resptrec-resources CREs
  • 28. References 1.Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease.J, et al. Can J Hosp Pharm. 2012. 2.Rx Files –COPD New Drugs, New Devices and Considerations for Best Practice Sept/15 3. The Science of Respiratory Medication Delivery Information taken from a 2014Webinar presentation by Dr. Janice Leung, MD 4.New inhaler devices - the good, the bad and the ugly.Lavorini F, et al. Respiration 2014;88:3–15 5.Inhaler Technique and Training in People With Chronic Obstructive Pulmonary Disease and Asthma:Choosing the Correct Inhaler Toby G.D. Capstick, MRPharmS; Ian J. Clifton, MD Medscape CME Released: 01/27/2012 6.Dry powder inhalers and the right things to remember: a concept review Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13 7.Not all asthma inhalers are the same: factors to consider when prescribing an inhaler Henry Chrystyna , David Pricea. Primary Care Respiratory Journal (2009) 8. http://www.specialconnections.ku.edu/?q=instruction/direct_instruction 9.Lung Association of Saskachewan-Inhaler videos and inhaler instruction sheets 10. Inhalation device requirements for patients' inhalation maneuvers PeterHaidl,et al

Editor's Notes

  1. Hi, my name is Donna Turner… I want to Thank you for inviting me to speak today about Inhaled medications used in Respiratory disease. I want to start by acknowledging all the mom’s in the audience today and wish you all a very happy Mother’s day!
  2. I am a Respiratory Therapist and Certified Respiratory Educator and I have worked in Prince Albert for 32 years –some acute care, home care and now in a primary care clinic. I taught the RespTrec programs for the Lung Ass.of Saskatchewan for13 years but have been a volunteer with the Lung Association since I moved to Prince Albert, supporting the Pink Panters COPD program back in the early 1990s. So now I am working at the Cooperative Health Centre Community clinic in Prince Albert where there are 2 Respiratory Therapist CREs and we provide spirometry and education to asthma and COPD patients along with providing evaluations to help diagnose patients with chronic cough, shortness of breath and other respiratory issues. We see approximately 1500 patients per year so we get lots of practice teaching people about their inhaled medications and see a lot of the gaps in good drug delivery to the lungs. I am passionate about Respiratory care and Respiratory health and always looking for new ways to improve people’s breathing!
  3. All devices have their own particular engineering principles for proper medication delivery. BUT…there are basic principles of how drugs are delivered to lungs you need to be aware of.
  4. Particles of medication need to get past the upper oropharynx then moving down to the diseased portions of the lung near the terminal bronchioles and alveoli. Proper size is in the 1-5um size. Too big, they deposit too high in the oropharynx and larger airways, too small and they are exhaled out. Increased risk of s.e. if there is deposit at the back of the throat and upper airway. DPIs are breath actuated-need a deep and forcible inhalation at the start of the inhalation to deliver the proper size particles. The dry powder inhalers are designed in such a way that the drug/carrier mixture is partly deagglomerated into inhalable drug particles by the inspiratory airflow of the patient. The extent of device emptying and deagglomeration, depends strongly on the inspiratory airflow and absolute lung capacity, both of which differ from patient to patient and which determines the fine particle dose of drug emitted from the dry powder inhaler. MDIs produce consistent, appropriate particle size on activation carried in a propellant. Respimat SMI produce fine mist of the proper size particles on activation without a propellant.
  5. No significant resistance with the MDI or SMI devices We need to know there is a resistance within a device and how this relates to the inspiratory flow required by the patient to disperse the drug into the appropriate particle size to then be inhaled into the diseased area of the lung. For DPIs additional effort is necessary to overcome the device specific resistance to reach the required flow rate. Low resistance device requires high flow rate to disperse drug-the resistance within the device is not helping with this maneuver. Medium resistance device requires moderate force to produce the required inspiratory flow rate. The resistance of the device is involved in breaking up the particles within device and then pt completes inhalation of med. High resistance device requires a significantly higher force to produce the required inspiratory flow rate.The resistance of the device is involved in breaking up the particles within device and then pt completes inhalation of med. The extent of device emptying and deagglomeration, which determines the fine particle dose of drug emitted from the dry powder inhaler, depends strongly on the inspiratory airflow and absolute lung capacity, both of which differ from patient to patient.
  6. MDI flow rate-less than 90 lpm. Slow and steady with breath hold at the end of inhalation. Too fast, too turbulent, less drug delivery. Spacer improves delivery. SMI flow rate-not dependent on the pt’s insp flow . Slow deep breath with a 10 second breath hold being ideal. Every breath-actuated DPI has a minimum threshold in terms of flow efficiency. If the inspiratory flow rate is too low (or the flow acceleration below a threshold), deagglomeration is insufficient and a reduced dose is delivered The limits of the DPIs in advanced disease is that all these devices require a fast deep inspiration and some pts cannot generate sufficient insp flow with DPIs. Not all COPD patients but some with advanced COPD pts have inadequate PIF which may limit use of some or all DPIs. Plugging the nose may allow a greater inspiratory flow through mouth. One of our patients was not able to generate the high inspiratory flow required for the Breezhaler device. He actually cut the end off of each capsule for his Breezhaler and dumped the med into the chamber so he could get the med out of the device! Snorting Onbrez! New drug deliver method?
  7. Advantage of DPI over MDI and SMI is that they are breath actuated and for some pre loaded. This is very appealing to some patients. Remember, just because you have severe COPD does not mean you will not be able to use DPIs.
  8. Using the IN Check dial for checking inspiratory flow of pts using DPI and to emphasize the slower inspiration required with the MDIs. What do we do with patients to know what inhaler will work or what they have won’t work? What tools? What signs? IN check dial helps determine inspiratory strength of patients against various resistances similar to the resistances of inhalers. Basically, if a pt cannot inspire strong enough for one type of inhaler, then we need to move to alternate device
  9. Eg:Pt could not turn the Respimat device due to her arthritis. Recent study in Vancouver found 59% of patients admitted to hospital for COPD AE misused their inhalation devices. 93% of those using an MDI made at least one critical error contributing to inadequate amts of drug delivered to lungs.
  10. Correct use of the inhalation devices will maximize the beneficial effects of therapy, while minimizing potential adverse effects.  Identification of poor inhaler technique is an integral part of the management of patients with asthma or COPD Provision of appropriate training is going to remain essential for the management of patients with asthma and COPD for the foreseeable future. Regular review of watching patients taking their inhaled medication is also important.
  11. Ideally if we all use the same instructions to teach proper inhaler use then the message gets across to our patients. These are just a few of the education tools available from the Lung Association of Saskatchewan. Videos are also available on line to direct your patients to when time is an issue.
  12. While educating someone on a new inhaler, sometimes it’s good to know some of the things that could go wrong and we can emphasize these points to ensure mastery!
  13. MDI No appreciable resistance Requires coordination of actuation and inhalation Med is delivered with a propellant. Can add spacer to improve drug delivery Needs slow deep inspiration with breath hold at the end of inspiration-breath in should be 3-5 sec long. Make sure they know how to check that if it is empty-count doses used per day or listen for med in canister or weight of canister helps indicate doses left.
  14. Discus Medium resistance device. Pre-loaded with med. Can double dose this device-if opened but no med inhaled, when you open again, the last dose is still there, added to the second dose. Pt must keep this device level once loaded because dose will fall from device if tipped. Make sure they understand to open lid, then open device.
  15. Turbuhaler High resistance dry powder device. Preloaded with medication. Need to hear the click after you turn one way then back to indicate drug is loaded. Requires a very strong deep inspiration to deliver med. Cannot double dose, will not load one dose on top of another if first dose not inhaled. When you shake device the drying agent is what you hear not the med. Med counter can be hard to see until it gets to last 20 doses, then red wheel appears. Red trainer is not indicating pt has enough inspiratory strength
  16. Handihaler High resistance capsule-based device. Requires a strong deep inspiration to deliver med. Requires insertion of med pill-watch for pt taking pill orally or rectally! Pt with issues with eyesight may struggle to see where to put capsule. Medication sensitive to light and temperature, keep in foil packaging until ready to use. Pt with tremors will have difficulty loading this med. Capsule is opaque and cannot see when capsule is empty-patients sometimes take it apart to see if it is empty! Pt needs to take 2 inhalations to make sure they empty capsule adequately. Some patients cannot draw the medication deep enough for effect. Make sure pt releases button on sides after puncturing capsule. Pt needs to wash hands after use.
  17. TTwisthaler High resistance dry powder device. Preloaded with medication. When pt takes off the lid, the med is loaded and ready to take. Pt has to tighten the lid down tight to make sure next dose is loaded. Pt needs to watch the number of doses decrease when they open device Requires a very strong deep inspiration to deliver med. Med counter easy to see and device locks out when the device is empty.
  18. Breezhaler. Low resistance capsule-based device. Require insertion of med pill-watch for pt taking pill orally or rectally! Medication sensitive to light and temperature, keep in foil packaging until ready to use. Pt with tremors will have difficulty with this med. Pt with issues with eyesight may struggle to see where to put capsule. Capsule is clear so easy to see if empty after taking dose. Fast inspiratory flow is required to deliver meds deep within lungs with this device which may be difficult for some patients Make sure pt releases buttons on sides after puncturing capsule. Static on pill can make it difficult to puncture pill-can puncture pill when device is open then close device and inhale
  19. Ellipta Medium resistance device. Preloaded with med. Device requires a fast inspiratory flow. Make sure they hear the click when they open the device fully Pt must not cover air vents on top of inhaler as this helps maximize inspiratory flow and subsequent drug delivery. Big numbers on the front make it easy to see. Easy to open for patients with arthritis or little hands. Must not blow into device or med will come out the air vents. Cannot double dose as it dumps one dose before another is loaded. Must keep unit level when opened to prevent dumping out dose.
  20. Genuair Medium resistance device. Pre loaded with med. Has acoustic and auditory signals to help pts know they have taken the inhaler properly. Taste can be a deterrent to use. The Genuair® locks after the last dose. Twice per day dosing may lead to non-adherence to schedule.
  21. Respimat Device delivers fine particles in a soft mist with no appreciable resistance Needs coordination of inhalation and drug delivery from device. Cannot use with Spacer to help with coordination until further studies. Close lips tightly around the mouthpiece without closing the air vents (on the sides of the mouthpiece) The high amount of fine particles exit device slower and for a longer period of time(1.5s) compared to the MDI. Higher lung deposition, no propellant. 10 secs breath hold required to improve drug delivery. Requires assembly prior to using device for the first time Needs priming to start or if not used for 30 days. When the arrow reaches the end of the scale the inhaler locks automatically.
  22. Teamwork really is how we improve our chances of success…..find the resources in your area who can help!